Tissue Regenix Group (LSE:TRX) Inventories, Finished Goods: £0.00 Mil (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Tissue Regenix Group Inventories, Finished Goods?

Tissue Regenix Group LSE:TRX Inventories, Finished Goods is £0.00 Mil as of Jun. 2025. The stock has 5 warning signs investors should review.

Tissue Regenix Group's quarterly finished goods increased from Jun. 2024 (£0.00 Mil) to Dec. 2024 (£0.70 Mil) but then declined from Dec. 2024 (£0.70 Mil) to Jun. 2025 (£0.00 Mil).

Tissue Regenix Group's annual finished goods declined from Dec. 2022 (£0.72 Mil) to Dec. 2023 (£0.56 Mil) but then increased from Dec. 2023 (£0.56 Mil) to Dec. 2024 (£0.70 Mil).

Tissue Regenix Group Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Tissue Regenix Group's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tissue Regenix Group Inventories, Finished Goods Chart

Tissue Regenix Group Annual Data
Trend Jan15 Jan16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.58 1.06 0.72 0.56 0.70

Tissue Regenix Group Semi-Annual Data
Jul15 Jan16 Jul16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.56 0.00 0.70 0.00

Tissue Regenix Group Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of £0.00 Mil mean?
Tissue Regenix Group (LSE:TRX) has a Inventories, Finished Goods of £0.00 Mil as of Jun. 2025. Finished goods are inventory items that are complete and ready to be sold. View historical data on Tissue Regenix Group and its competitors.
Is Tissue Regenix Group's Inventories, Finished Goods too high?
Tissue Regenix Group's current Inventories, Finished Goods is £0.00 Mil.
How does Tissue Regenix Group's Inventories, Finished Goods compare to VRTX and REGN?
Tissue Regenix Group's Inventories, Finished Goods of £0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Biotechnology company?
A good Inventories, Finished Goods depends on the Biotechnology industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Tissue Regenix Group and its competitors. Tissue Regenix Group's current Inventories, Finished Goods is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tissue Regenix Group stock overvalued right now?
Tissue Regenix Group (LSE:TRX) has a current Inventories, Finished Goods of £0.00 Mil. The stock's GF Value™ is £0.87, compared to a current price of £0.07 — trading 91.7% below its estimated fair value. The current Inventories, Finished Goods is £0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Tissue Regenix Group (LSE:TRX), the current Inventories, Finished Goods is £0.00 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tissue Regenix Group Business Description

Address Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY
Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.